Key developments in biotech include a father’s significant efforts to create a gene therapy for his daughter Grace, who suffers from the rare disorder NGLY1 deficiency. With an investment of $70 million, Matt Wilsey assembled a team of experts to develop an experimental treatment that initially led to hospitalization but has resulted in recovery. Additionally, the White House is close to deciding on a new FDA chief, and the Trump administration is encouraging drug manufacturers to bring generic production back to the U.S.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.statnews.com/2026/07/09/biotech-news-prime-wins-beam-arbitration-clearing-path-to-clinic/
